The Manufacturers Life Insurance Company Acquires 39,760 Shares of iShares Biotechnology ETF $IBB

The Manufacturers Life Insurance Company boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 64.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 101,838 shares of the financial services provider’s stock after purchasing an additional 39,760 shares during the period. The Manufacturers Life Insurance Company’s holdings in iShares Biotechnology ETF were worth $19,369,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in IBB. Sequoia Financial Advisors LLC lifted its holdings in iShares Biotechnology ETF by 5.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,258 shares of the financial services provider’s stock valued at $620,000 after purchasing an additional 166 shares during the last quarter. Tidal Investments LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter valued at about $1,512,000. NorthRock Partners LLC lifted its position in iShares Biotechnology ETF by 51.8% during the 2nd quarter. NorthRock Partners LLC now owns 1,940 shares of the financial services provider’s stock worth $369,000 after buying an additional 662 shares in the last quarter. Community Bank N.A. lifted its position in iShares Biotechnology ETF by 5.2% during the 2nd quarter. Community Bank N.A. now owns 1,483 shares of the financial services provider’s stock worth $282,000 after buying an additional 73 shares in the last quarter. Finally, RFG Advisory LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $349,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $202.93 on Friday. iShares Biotechnology ETF has a 1-year low of $138.79 and a 1-year high of $217.12. The firm has a 50-day moving average price of $199.42 and a two-hundred day moving average price of $181.37.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.